OBJECTIVES: Although septal myectomy is the technique of choice for hypertrophic cardiomyopathy, the surgical management of concomitant mitral valve lesions is controversial. Various complex surgeries have been proposed to address mitral valve lesions. We propose a simple option using an edge-to-edge mitral valve repair through the aortic valve in addition to the septal myectomy.
INTRODUCTION
Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular wall thickness > _ 15 mm in one or more myocardial segments that is not solely explained by abnormal loading conditions like aortic stenosis or systemic hypertension [1] . Different morphologic anomalies of the mitral valve apparatus have been described in these patients over time, mainly dynamic but also organic with leaflets elongation and anterior displacement or anomalous insertion of the anterolateral papillary muscle [2] . So septal hypertrophy, aorto-mitral angle and mitral valve abnormalities contribute overall in the development of the systolic anterior motion (SAM) of the mitral valve, which determines left ventricular outflow tract (LVOT) obstruction in one third of the HCM population [3] . The spectrum of clinical manifestations of HCM is broad and may vary from asymptomatic courses to severe dyspnoea, syncope or sudden cardiac death. An invasive treatment aiming at septal reduction is indicated in patients presenting LVOT obstruction with resting or maximum provoked gradient > _ 50 mmHg and who are symptomatic despite maximal optimal medical treatment. Because of a better knowledge of the mitral valve role in the pathophysiology of HCM, current guidelines clearly state that surgical septal myectomy, rather than percutaneous septal alcohol ablation, is recommended in patients with an indication for septal reduction therapy and other lesions requiring surgical intervention (e.g. mitral valve repair/replacement and papillary muscle intervention) [1] .
Ventricular septal myectomy using the Morrow procedure is the technique of choice for HCM and often enough to restore a normal motion of the anterior leaflet when the origin of the SAM is mainly dynamic. However, in case of organic mitral valve anomalies involving the leaflets or the subvalvular apparatus, the surgical management of associated mitral valve lesions is still matter of debate [4] . In fact several surgical techniques have been suggested alone or in combination to treat the different abnormalities of the mitral valve in HCM patients [5] [6] [7] [8] [9] [10] .
In the context of degenerative mitral valve repair, the edge-toedge technique has been proposed to treat complex lesions [11, 12] and we herein propose its application in case of mitral anomalies associated with HCM.
MATERIALS AND METHODS

Patient population
Patients addressed to our Department of Cardiac Surgery with a diagnosis of symptomatic HCM and who were operated for septal myectomy associated to the edge-to-edge mitral valve repair from January 2009 to March 2016 were included in this analysis. During the same time period, we excluded from our study patients with HCM: (i) treated medically and regularly followed-up in our Department of Cardiology (n = 15); (ii) treated with a percutaneous alcohol septal ablation procedure (n = 24) and (iii) presenting primary, organic lesions of the mitral valve requiring mitral valve replacement (n = 8). We performed an observational analysis of our prospectively collected database. Approval of the Institutional Review Board of our hospital was obtained. Written informed consent for every data analysis was not obtained according to French legislation because this observational study did not modify existing diagnostic or therapeutic strategies.
Preoperative evaluation
The dedicated multidisciplinary Heart Team of our hospital, including cardiologists, echocardiographists, invasive cardiologists, electrophysiologists, geneticists, radiologists, anesthesiologists and cardiac surgeons, performed the baseline assessment of HCM patients.
Transthoracic echocardiography (TTE) provided the quantification and extension of myocardial hypertrophy as well as left ventricular function. Resting or provoked (with exercise or Valsalva manoeuvres) intraventricular gradients were measured. Moreover, it allowed for a morphologic evaluation of the mitral valve coupled with a functional analysis with respect to the presence of SAM and the degree of mitral regurgitation (MR). Anomalies of the mitral subvalvular apparatus were also noted. The degree of MR was scored on a 5-point scale (0 = absent or trace, 1 = trivial, 2 = mild, 3 = moderate, 4 = severe). Preoperative transoesophageal echocardiography (TEE) was performed only in patients with challenging transthoracic windows or to best define the mechanism of MR with concomitant organic lesions. This echocardiographic evaluation allowed for the identification of those patients with primary, organic MR requiring a complex mitral valve repair or replacement through a standard left atrium approach. Cardiac magnetic resonance imaging was always part of the baseline evaluation, whereas coronary angiography was performed if indicated according to the guidelines.
Finally, the surgical indication followed current European guidelines [1] .
Surgical technique
Perioperative TEE was mandatory to confirm the preoperative findings and to assess the quality of the surgical result at the end of the operation after weaning from cardiopulmonary bypass. Patients were operated through a standard sternotomy after institution of cardiopulmonary bypass between a double-stage single venous cannula and an aortic cannula. Myocardial protection was achieved with antegrade cold crystalloid cardioplegic arrest. Our surgical technique was previously described [13] . Briefly, the whole procedure is performed through the transverse aortotomy without any direct opening of the left atrium. A modified Morrow procedure represents the first step of the operation. The resection is then extended deeply into the left ventricle towards the papillary muscles and anomalous papillary muscles are resected or detached from the left ventricular wall or leaflets. The second step consists in the edge-to-edge U suture, reinforced by two autologous pericardial pledgets (Fig. 1) . The edge-to-edge mitral valve repair is performed after careful identification of P2 and A2 scallops between the paramedial chordae on each side. Concomitant procedures were performed, if indicated.
Follow-up
A TTE was performed before hospital discharge to confirm the surgical results. The clinical follow-up was done by telephone contact with each patient. Echocardiographic follow-up was performed in our Department of Cardiology or directly by the referring cardiologist.
Clinical outcomes and statistical analysis
We reviewed demographics, preoperative, intraoperative and postoperative data collected in the computerized medical charts of our hospital. The primary endpoint of our study was the degree of residual MR at the latest echocardiographic follow-up. The secondary endpoints were the New York Heart Association (NYHA) functional class, presence of SAM, septal thickness and residual resting or maximum provoked intraventricular gradient at the latest clinical and echocardiographic follow-up.
Statistical analysis was performed using SPSS software, version 23.0 (IBM Corp., Armonk, NY, USA). Quantitative variables are presented as mean ± standard deviation and were compared by using the paired Student's t-test or the Wilcoxon signed rank test, depending on their normality assessed by the KolmogorovSmirnov test. Ordinal variables are presented as counts and percentages and were compared by using the Wilcoxon signed rank test. Categorical variables are presented as counts and percentages and were compared by using the McNemar's test. For each variable, analysis was only performed on cases with matched data (i.e. excluding cases with missing data). A level of 0.05 was used to test for significance.
RESULTS
Over the study period, we operated 22 patients. The mean age was 48.5 ± 13.7 (range, 27-73) years, and there was a predominance of males (59%). Table 1 summarizes the baseline characteristics of our study population. The mean preoperative NYHA functional class was 2.5 ± 0.6 despite optimal pharmacologic treatment with b-blockers (91%) and/or calcium channel blockers (14%). One (5%) patient was in NYHA functional class I, but he was symptomatic for chest pain. Seven (32%) patients experienced at least one episode of syncope. Fourteen (64%) patients performed genetic testing before surgery and we identified a gene mutation in 9 (64%) of them. The identified mutations were as follows: MYBPC3 (n = 7, 78%), MYH7 (n = 1, 11%) and TPM I (n = 1, 11%). Table 2 lists the preoperative echocardiographic evaluation. The analysis of the contractility of the left ventricle confirmed the presence of a mean 'hyperdynamic' systolic function, which is typical of HCM patients. Two (9%) patients presented a left ventricular ejection fraction < 60%. The mean interventricular septum diameter was 25.8 ± 5.4 (range, 19-36) mm, whereas the mean resting intraventricular gradient was 75.4 ± 30.5 (range, 8-138) mmHg. The maximum provoked intraventricular gradient was performed in 11 (50%) patients and reached 103.5 ± 37.9 (range, 60-170) mmHg. Every patient (100%) displayed an SAM of the anterior mitral leaflet, whereas morphologic abnormalities of the papillary muscles were found in 4 (18%) patients. The mean MR was 2.4 ± 0.9 and 11 (50%) patients displayed grade 3 or 4 MR. Left atrial enlargement was present in 17 (77%) patients. Coronary angiography was performed in 20 (91%) patients and revealed no critical coronary lesions.
Concomitant procedures were performed in 3 (14%) patients: aortic valve replacement (n = 1, 5%) and radiofrequency pulmonary veins isolation (n = 2, 9%). The mean aortic crossclamping time was 55.1 ± 9.8 (range, 42-76) minutes, whereas the mean cardiopulmonary bypass time was 68.2 ± 10.2 (range, 54-88) min. After weaning from cardiopulmonary bypass and under optimal haemodynamic and filling conditions, intraoperative TEE showed no residual MR > _ grade 2 and no patient displayed SAM of the anterior mitral leaflet. There were no inhospital deaths. During the postoperative course, 2 (9%) patients required the implantation of a pacemaker due to atrioventricular block. The TTE performed before hospital discharge showed a statistically significant reduction of the septal thickness (19.4 ± 7.9 vs 27.1 ± 5.7 mm, P < 0.001), resting intraventricular gradient (11.3 ± 9.9 vs 77.5 ± 34.5 mmHg, P < 0.001), presence of SAM (5% vs 100%, P < 0.001) and degree of MR (1.1 ± 0.9 vs 2.4 ± 0.9 mmHg, P < 0.001) when compared with preoperative assessment.
After a mean follow-up of 26.3 ± 20.5 (range, 1.8-89.9) months, the study population experienced a significant clinical improvement. The mean preoperative NYHA functional class was 2.5 ± 0.6 and 1.2 ± 0.4 at last follow-up (P < 0.001). Twelve (55%) patients were in NYHA functional classes III-IV preoperatively, whereas 100% were in classes I-II at follow-up (P < 0.001; Fig. 2 ). The echocardiographic follow-up confirmed the immediate postoperative results with a sustained significant reduction of the septal thickness (18.5 ± 5.7 vs 25.9 ± 5.3 mm, P < 0.001), resting intraventricular gradient (4.8 ± 7.6 vs 79.6 ± 29.3 mmHg, P < 0.001), presence of SAM (0% vs 100%, P < 0.001) and degree of MR (1.2 ± 0.6 vs 2.4 ± 0.9 mmHg, P = 0.002) when compared with the baseline values. The proportion of grade 3 or 4 MR decreased from 50% preoperatively to 0% at last follow-up (P < 0.001). Mean transmitral gradient was 3.5 ± 2.2 (range, 1.2-7) mmHg.
DISCUSSION
The prevalence of HCM in the general population is high, and the disease is an autosomal dominant trait in up to 60% of cases caused by mutations in cardiac sarcomere protein genes [14] . Left ventricular hypertrophy, mainly localized in the interventricular septum, is the leading diagnostic feature of HCM, and the enlarged Morrow procedure remains the gold standard and main step of any surgery for HCM. The surgical myectomy effectively relieves symptoms related to LVOT obstruction with a subsequent restoration of the quality of life and improves overall survival at long-term follow-up [15] [16] [17] . The present report, albeit with a shorter follow-up, is consistent with these previous experiences [15] [16] [17] as the enlarged Morrow procedure significantly reduced the septal thickness and resting intraventricular gradient. As a consequence, the patients experienced a clinical improvement that was maintained during the follow-up. The majority of patients were asymptomatic at the latest telephone contact and approximately 20% of the population was in NYHA functional class II. Moreover, there were any deaths either in the immediate postoperative period or during the follow-up.
The role of the mitral valve in hypertrophic cardiomyopathy
The mitral valve plays a key role in the pathophysiologic mechanisms of HCM acting as a complex anatomic and functional unit. Initially, the presence of the SAM was explained by a simple Venturi effect, which is a suction phenomenon towards the hypertrophied septum as a consequence of accelerated LVOT flow [18] . The contribution of the morphologic abnormalities of the mitral valve in the development of SAM was then clearly identified after the observation that SAM can be present without a diagnosis of HCM [3, 19] and begins before LVOT flow acceleration [3, 20] . Moreover, the role of the mitral valve in HCM is underscored by the high rate of persistent SAM in percutaneous alcohol septal ablation, as this procedure targets only the hypertrophied septum [21] . Nonetheless, the issue whether the surgical intervention should also involve the mitral valve is still controversial. Some centres systematically associate mitral valve surgery to septal myectomy, whereas others do not. Many surgical techniques have been described to treat MR associated with HCM, which were sometimes contradictory (anterior leaflet extension or resection) and probably illustrated confusion in the interpretation of the disease. A vertical-i.e. parallel to the long axis-plication was initially devised to correct the anterior leaflet elongation [5] . It allowed for decreasing leaflet width and limiting billowing but it often perturbed the coaptation line resulting in central MR [2] . Other authors have so proposed a horizontal-i.e. perpendicular to the long axis-plication of the anterior leaflet. This technique takes part of an intellectual more appealing but technical more complicated approach termed the 'RPR repair' as it consists of resection (R) of the septum, plication (P) of the anterior leaflet and release (R) of abnormal papillary muscle attachments [22] . They suggest four or five mattress sutures placed across the pliable main body of the leaflet, within the aorto-mitral curtain. The total amount of plication is variable between 2 and 6 mm as a function of intraoperative findings, thus limiting its reproducibility. The echocardiographic results of this combined approach at midterm follow-up were good with very low rate of both residual SAM and significant (grade 3 or 4) MR [6, 23] .
Alternatively, an extension with autologous pericardial patch has been proposed to stiffen the buckling anterior leaflet [7] . From a clinical standpoint, this technique coupled with septal myectomy led to long-term symptoms improvement. From an echocardiographic standpoint, grade 3 or 4 MR was present in 2% of the study population at long-term follow-up but a quite high proportion (7%) of patients displayed the persistence of SAM [24] . More recently, Dulguerov et al. [8] used a two-step technique combining complete septal myectomy and mitral valve repair in a small series of 16 patients. The classic transaortic septal myectomy is completed through a transmitral approach after detaching the anterior leaflet. The anterior leaflet is then reconstructed with an autologous pericardial patch doubling its surface and moving the coaptation plane posteriorly away from the septum. The operation is finalized with a posterior leaflet resection and an annuloplasty. The results of this technique at short-term follow-up were satisfactory. Even if the correction of the mitral valve disease strictly follows the principles of the functional analysis, this technique appears complicated and not prone to a widespread application as witnessed by longer mean cross-clamping and cardiopulmonary bypass time (105 and 168 min, respectively) in such an experienced team in conservative mitral valve surgery. Finally, other investigators have suggested various surgical techniques targeting specifically the subvalvular apparatus. Ferrazzi et al. [9] proposed a transaortic cutting of thickened and fibrotic mitral valve secondary chordae. The authors explained that these abnormal secondary chordae contribute to displace the anterior leaflet into the LVOT and selected cutting of abnormal chordae moves the mitral valve apparatus and leaflet coaptation point away from the LVOT. This technique was reserved to HCM patients with mild septal hypertrophy (mean preoperative septal thickness of 17 mm) and was associated to a shallow septal myectomy. This experience included 39 out of 268 HCM patients over a 13-year period highlighting a selected minority of patients that could benefit from this approach. Furthermore, the Cleveland Clinic team reported the short-term outcomes of patients with HCM who underwent papillary muscle reorientation with or without myectomy [10] . This technique provides for a papillary muscle realignment placing one or more pledgeted mattress suture from the most posterior papillary muscle head through the anterior head. The procedural success rate was high, and all patients were asymptomatic at short-term follow-up. Only one patient (without myectomy) required an early reoperation of mitral valve replacement due to sudden worsening dyspnoea, increased LVOT gradient and persistent SAM. This technique allows for a safe reorientation of one or more papillary muscle heads away from the LVOT while preserving mitral valve function. However, the authors stressed that imaging protocols that objectively detail papillary muscle morphology need yet to be established and validated prospectively and, at present, this morphologic evaluation is based on a subjective visual assessment.
The rationale for the edge-to-edge mitral valve repair in hypertrophic cardiomyopathy
The edge-to-edge technique has been introduced in the 1990s as an attractive option in the setting of mitral valve repair. It provides satisfactory long-term results especially for degenerative MR with anterior leaflet or bileaflet prolapse [25] . However, to the best of our knowledge, there is a paucity of data about its application in the context of HCM [26] [27] [28] [29] . Nonetheless, this technique displays several advantages that could best fit to the HCM population.
It is a simple and reproducible technique represented by an edge-to-edge suture of the anterior and posterior mitral leaflets. Moreover, it can be easily performed through the aortic orifice without the need for a more questionable direct approach of the left atrium. Taken together, these practical features allow for a fast surgical technique. The cross-clamping and cardiopulmonary bypass times of our experience are shorter than those reported in previous papers describing other techniques of mitral valve surgery in HCM patients [6, 8, 16] . Although the absence of ring annuloplasty has been recognized as a risk factor for late edgeto-edge failure [29] , this finding emerged in studies focusing on degenerative MR and should not be applied to HCM, where the size of the annulus is normal.
Our echocardiographic short-term follow-up reported good results without any case of recurrent grade 3 or 4 MR. Any patient experienced an SAM of the mitral valve at the latest control. The only case of early partial SAM found at the TTE performed before hospital discharge was not further encountered. This early partial SAM (the edge-to-edge limits the excursion of the anterior leaflet) could probably be explained by a non-optimal filling condition under diuretic treatment, which is regularly used in the immediate postoperative course of any open-heart surgery. The absence of SAM is consistent with the Alfieri's team long-term results of the edge-to-edge technique for degenerative MR [29] . Besides, the edge-to-edge repair can safely be used as a surgical strategy to treat or prevent SAM, avoiding more complicated alternatives [30] . This technique in fact fixes the coaptation point preventing the displacement of the anterior mitral leaflet towards the LVOT. Because of our echocardiographic results, any patient required a reoperation on the mitral valve. Conversely, Bhudia et al. [26] performed a reoperation of mitral valve replacement in 2 out of 14 HCM patients operated according to the edge-toedge technique. The mechanism was a residual intraventricular gradient associated with myectomy and not a failure of the edge-to-edge approximation itself occurred 15 days and 16 months after the index surgery, respectively. More recently, Cui et al. [29] reported a reoperation of mitral valve replacement in one out of seven HCM patients who underwent septal myectomy associated to the edge-to-edge technique.
Study limitations
We acknowledge that our study displays several limitations. First, it is an observational analysis of a single-centre experience showing its intrinsic limitations. The small sample size is a limiting factor that could undermine the statistical power of our analysis. We did not use a control group performing isolated septal myectomy for comparison with our patient population, and we cannot exclude that a part of our patient could have had an acceptable result without the addition of the edge-to-edge repair. A complete septal myectomy using the Morrow procedure coupled with the fixation of the coaptation point through the edge-toedge mitral valve repair could prevent the displacement of the anterior mitral leaflet towards the LVOT, but the rationale of our strategy is not supported by quantitative data of the mitral valve apparatus. The results presented below must be validated in further studies with larger cohorts of patients and longer follow-up.
CONCLUSION
Septal hypertrophy and SAM of the anterior mitral leaflet are the leading morphologic features of HCM. The SAM plays a key role in the physiopathology of dynamic LVOT obstruction found in these patients. The enlarged Morrow procedure remains the first step of any surgery for HCM owing to its good clinical and echocardiographic long-term validated results. The edge-to-edge technique performed through the aortic orifice is a simple, reproducible and fast technique that is helpful to secure the coaptation between the two leaflets of the mitral valve, particularly in the presence of organic mitral valve lesions.
